Investment

If the boom in biotech IPOs is over family offices won’t be happy

A recent surge in biotech IPOs haven’t quite met investor expectations raising some concerns about future listings in the sector from backers like family/private investment offices. 

Subscribe

You will need a Premium+ Subscription to read this article.

Exclusive news, analysis and research on global family enterprise and private investment offices

SUBSCRIBE TODAY

Already have an account? Sign in

You need a Premium subscription.

To read Premium articles please subscribe.

SUBSCRIBE TODAY

Already have an account? Sign in

You've reached the end.

Continue reading free articles by registering as a Member.
Or choose a Premium Plan.

SUBSCRIBE TODAY

Already have an account? Sign in

ATHOS Service
  • Sector: Family Office
  • Country: DE
More Details

What to read next

Premium

Series A and C dominate deals this week, which include a novel fire protection group, five Swedish family offices backing a fintech platform, and one prominent family office backing an advertising/marketing…
Investment

Swedish family offices have come together to invest in a mobile payments platform as fintech investing continues to attract strong interest from private investment groups
Investment

New research shows that family offices' influence in private markets has grown nearly exponentially, underlining their power in global capital markets

Leave a Reply